Free Trial
→ Radical shift coming to the stock market (read this ASAP) (From Weiss Ratings) (Ad) Buy BAK Stock  Free BAK Stock Alerts

Braskem (BAK) Financials

Braskem logo
$3.30 -0.18 (-5.03%)
Closing price 04/15/2025 03:59 PM Eastern
Extended Trading
$3.30 -0.01 (-0.30%)
As of 04/15/2025 04:05 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.
Compare
Annual Income Statements for Braskem

Annual Income Statements for Braskem

This table shows Braskem's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Net Income / (Loss) Attributable to Common Shareholders		 758 -534 1,197 750 -682 -1,413 2,500 -162 -1,008 -2,067
Consolidated Net Income / (Loss)		 697 -224 1,182 739 -657 -1,351 2,504 -155 -1,008 -1,949
Net Income / (Loss) Continuing Operations		 696 -445 1,178 739 -657 -1,351 2,504 -162 -1,009 -1,949
Total Pre-Tax Income 		1,115 -213 1,589 929 -1,145 -1,864 3,222 2.27 -1,278 -2,868
Total Operating Income		 1,740 553 1,545 1,072 -1,528 -1,090 3,518 -246 -2,076 -1,455
Total Gross Profit		 2,572 3,897 3,950 2,944 1,603 2,159 5,750 2,149 623 970
Total Revenue		 11,840 12,653 14,873 14,947 13,019 11,271 18,947 17,301 13,392 12,518
Operating Revenue		 11,840 12,653 14,873 14,947 13,019 11,271 18,947 17,301 13,392 12,518
Total Cost of Revenue		 9,269 10,023 12,407 12,921 13,488 11,587 14,555 16,554 14,485 13,149
Operating Cost of Revenue		 9,269 10,023 12,407 12,921 13,488 11,587 14,555 16,554 14,485 13,149
Total Operating Expenses		 560 2,077 920 954 1,059 774 874 992 983 824
Selling, General & Admin Expense		 277 827 870 897 997 726 821 922 904 749
Research & Development Expense		 43 50 51 57 62 48 53 71 79 75
Total Other Income / (Expense), net		 -625 -765 44 -143 383 -774 -296 248 799 -1,430
Interest & Investment Income		 148 221 182 152 212 116 284 260 346 278
Other Income / (Expense), net		 26 -987 -138 -295 171 -890 -579 -12 453 -1,708
Income Tax Expense		 419 - 411 190 -488 -514 717 164 -268 -919
Net Income / (Loss) Attributable to Noncontrolling Interest		 61 98 -15 -10 25 62 4.13 - - 118
Basic Earnings per Share		 - - - - ($6.38) ($25.23) $35.73 - - ($6.89)
Weighted Average Basic Shares Outstanding		 - - 797.26M 451.67M 451.67M 797.22M 796.31M 797.21M 797.21M 797.21M
Diluted Earnings per Share		 - - - - ($6.37) ($25.20) $35.68 - - ($6.89)
Weighted Average Diluted Shares Outstanding		 - - 797.26M 451.67M 451.67M 797.22M 796.31M 797.21M 797.21M 797.21M
Weighted Average Basic & Diluted Shares Outstanding		 - - 797.26M 451.67M 451.67M 797.22M 796.31M 797.21M 797.21M 797.21M

Quarterly Income Statements for Braskem

No quarterly income statements for Braskem are available.

Annual Cash Flow Statements for Braskem

This table details how cash moves in and out of Braskem's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Net Change in Cash & Equivalents		 -1,017 -1,149 -2,823 117 -5,483 3,209 -1,117 711 -834 -67
Net Cash From Operating Activities		 -52 260 -1,847 1,176 -4,652 3,734 564 1,883 86 533
Net Cash From Continuing Operating Activities		 -52 260 -1,847 1,176 -4,652 3,734 564 1,883 86 533
Net Income / (Loss) Continuing Operations		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Depreciation Expense		 537 825 884 771 904 779 749 895 1,073 800
Non-Cash Adjustments To Reconcile Net Income		 -802 507 -2,312 48 -5,782 3,151 -751 952 -1,404 -309
Changes in Operating Assets and Liabilities, net		 213 -1,072 -419 358 226 -196 566 35 417 41
Net Cash From Investing Activities		 -843 -795 -674 -673 -664 -525 -606 -917 -919 -599
Net Cash From Continuing Investing Activities		 -843 -795 -674 -673 -664 -525 -606 -917 -919 -599
Purchase of Property, Plant & Equipment		 -843 -795 -686 -697 -667 -531 -614 -917 -934 -608
Sale of Property, Plant & Equipment		 0.32 0.17 12 25 3.13 6.38 7.18 0.38 15 9.06
Net Cash From Financing Activities		 -122 -614 -302 -387 -166 -0.46 -1,075 -255 -1.44 -0.97
Net Cash From Continuing Financing Activities		 -122 -614 -302 -387 -166 -0.46 -1,075 -255 -1.44 -0.97
Payment of Dividends		 -122 -614 -302 -387 -166 -0.46 -1,075 -255 -1.44 -0.97
Cash Interest Paid		 -473 562 650 494 557 527 517 550 732 689

Quarterly Cash Flow Statements for Braskem

No quarterly cash flow statements for Braskem are available.

Annual Balance Sheets for Braskem

This table presents Braskem's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2016 2017 2018 2019 2020 2021 2022 2023 2024
Total Assets		 15,930 15,921 15,155 16,952 16,573 16,604 16,657 18,907 16,425
Total Current Assets		 4,886 5,259 5,421 5,820 6,582 7,048 6,519 7,716 5,989
Cash & Equivalents		 2,060 1,140 1,430 1,693 2,669 1,557 2,358 2,924 2,423
Short-Term Investments		 369 696 615 421 705 633 464 1,050 301
Accounts Receivable		 558 1,078 909 722 1,001 1,459 749 771 703
Inventories, net		 1,721 2,005 2,187 1,897 1,614 2,930 2,654 2,583 2,213
Current Deferred & Refundable Income Taxes		 254 - 218 418 230 256 219 301 222
Plant, Property, & Equipment, net		 9,018 8,986 8,185 8,041 6,917 6,677 0.00 0.00 0.00
Total Noncurrent Assets		 1,300 1,352 1,534 3,092 3,022 2,802 2,906 3,216 3,853
Long-Term Investments		 37 3.12 20 18 11 14 28 34 71
Noncurrent Note & Lease Receivables		 65 45 53 70 48 68 36 100 88
Intangible Assets		 863 823 706 687 545 516 572 641 548
Noncurrent Deferred & Refundable Income Taxes		 335 352 690 1,284 1,849 1,706 1,509 1,610 2,529
Other Noncurrent Operating Assets		 - 128 64 1,033 569 499 761 831 617
Total Liabilities & Shareholders' Equity		 15,930 15,921 15,155 16,952 16,573 16,604 16,657 18,907 16,425
Total Liabilities		 10,203 9,684 9,596 13,482 12,675 13,221 13,611 16,486 15,908
Total Current Liabilities		 7,052 5,605 5,867 4,035 5,465 4,519 4,575 5,048 4,572
Short-Term Debt		 798 366 197 2,503 1,111 2,444 2,248 2,584 2,677
Accounts Payable		 2,158 1,611 2,310 2,500 2,005 2,461 2,616 3,179 3,067
Current Employee Benefit Liabilities		 50 - 166 155 157 210 157 171 167
Other Taxes Payable		 173 461 111 80 183 182 93 80 101
Other Current Liabilities		 8.93 56 70 360 356 251 408 478 296
Total Noncurrent Liabilities		 8,319 8,664 7,831 11,935 11,852 10,972 10,926 13,184 12,545
Long-Term Debt		 6,374 6,696 6,268 7,069 7,888 6,084 6,511 8,316 8,256
Capital Lease Obligations		 - - 23 498 445 445 606 609 535
Asset Retirement Reserve & Litigation Obligation		 - - - - - 207 222 226 137
Noncurrent Deferred & Payable Income Tax Liabilities		 7.41 320 138 109 293 599 347 390 293
Noncurrent Employee Benefit Liabilities		 - 59 53 97 91 87 93 117 89
Other Noncurrent Operating Liabilities		 407 116 85 109 145 251 311 338 290
Total Equity & Noncontrolling Interests		 529 1,652 1,457 982 -744 1,113 1,156 676 -692
Total Preferred & Common Equity		 842 1,902 1,683 1,216 -424 1,411 1,385 823 -773
Total Common Equity		 842 1,902 1,683 1,216 -430 780 1,132 923 -694
Common Stock		 2,472 2,281 1,947 1,880 1,454 1,355 1,522 1,658 1,301
Retained Earnings		 - -66 -66 0.00 -872 - 0.00 -564 -2,269
Accumulated Other Comprehensive Income / (Loss)		 -1,943 -1,560 -1,449 -1,184 -1,003 -569 -393 -176 272
Other Equity Adjustments		 328 1,262 1,264 532 0.00 0.62 3.22 5.56 2.10
Noncontrolling Interest		 -313 -250 -226 -234 -320 -298 -230 -147 82

Quarterly Balance Sheets for Braskem

No quarterly balance sheets for Braskem are available.

Annual Metrics and Ratios for Braskem

This table displays calculated financial ratios and metrics derived from Braskem's official financial filings.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Growth Metrics		 - - - - - - - - - -
Revenue Growth		 0.00% 6.86% 17.55% 0.50% -12.90% -13.43% 68.10% -8.69% -22.59% -6.53%
EBITDA Growth		 0.00% -83.03% 486.34% -32.45% -129.28% -164.91% 407.16% -82.71% -186.32% -329.18%
EBIT Growth		 0.00% -124.57% 424.30% -44.77% -274.61% -45.90% 248.40% -108.77% -530.06% -94.84%
NOPAT Growth		 0.00% -64.35% 195.95% -25.54% -225.41% 28.67% 458.40% 540.59% -108.30% 29.93%
Net Income Growth		 0.00% -132.15% 627.45% -37.48% -188.88% -105.58% 285.43% -106.20% -548.88% -93.38%
EPS Growth		 0.00% 0.00% 0.00% 0.00% 0.00% -295.41% 241.58% 0.00% 0.00% 0.00%
Operating Cash Flow Growth		 0.00% 598.37% -811.13% 163.66% -495.58% 180.27% -84.88% 233.55% -95.45% 521.47%
Free Cash Flow Firm Growth		 0.00% 0.00% 101.67% 882.04% -209.66% 123.44% 522.93% 913.44% -104.22% -54.78%
Invested Capital Growth		 0.00% 0.00% 10.03% -6.42% 6.20% -10.78% 2.65% -77.15% -17.49% 33.41%
Revenue Q/Q Growth		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
EBITDA Q/Q Growth		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
EBIT Q/Q Growth		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
NOPAT Q/Q Growth		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Net Income Q/Q Growth		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
EPS Q/Q Growth		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Cash Flow Q/Q Growth		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Free Cash Flow Firm Q/Q Growth		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Invested Capital Q/Q Growth		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Profitability Metrics		 - - - - - - - - - -
Gross Margin		 21.72% 30.80% 26.56% 19.70% 12.32% 19.15% 30.35% 12.42% 4.65% 7.75%
EBITDA Margin		 19.45% 3.09% 15.41% 10.36% -3.48% -10.65% 19.46% 3.69% -4.11% -18.87%
Operating Margin		 14.70% 4.37% 10.39% 7.17% -11.74% -9.67% 18.57% -1.42% -15.50% -11.62%
EBIT Margin		 14.92% -3.43% 9.46% 5.20% -10.42% -17.57% 15.51% -1.49% -12.12% -25.27%
Profit (Net Income) Margin		 5.89% -1.77% 7.95% 4.95% -5.05% -11.98% 13.22% -0.90% -7.53% -15.57%
Tax Burden Percent		 62.53% 105.45% 74.38% 79.57% 57.36% 72.44% 77.74% -6,841.67% 78.88% 67.96%
Interest Burden Percent		 63.13% 48.98% 112.95% 119.53% 84.40% 94.16% 109.65% -0.88% 78.70% 90.66%
Effective Tax Rate		 37.61% 0.00% 25.88% 20.43% 0.00% 0.00% 22.26% 7,233.34% 0.00% 0.00%
Return on Invested Capital (ROIC)		 0.00% 7.86% 11.08% 8.13% -10.23% -7.49% 28.09% 289.12% -70.68% -46.94%
ROIC Less NNEP Spread (ROIC-NNEP)		 0.00% -5.26% 11.47% 6.86% -5.76% -13.32% 25.68% -69.75% -31.62% -89.66%
Return on Net Nonoperating Assets (RNNOA)		 0.00% -92.62% 97.32% 39.41% -43.65% -1,131.61% 1,331.43% -302.82% -39.39% 24,415.22%
Return on Equity (ROE)		 0.00% -84.76% 108.40% 47.54% -53.88% -1,139.10% 1,359.51% -13.69% -110.07% 24,368.28%
Cash Return on Invested Capital (CROIC)		 0.00% -192.14% 1.52% 14.76% -16.24% 3.91% 25.47% 414.74% -51.51% -75.56%
Operating Return on Assets (OROA)		 0.00% -2.72% 8.84% 5.00% -8.45% -11.81% 17.71% -1.55% -9.13% -17.90%
Return on Assets (ROA)		 0.00% -1.41% 7.42% 4.76% -4.09% -8.06% 15.10% -0.93% -5.67% -11.03%
Return on Common Equity (ROCE)		 0.00% -134.89% 136.37% 54.81% -64.04% -3,773.16% 1,292.24% -11.55% -123.53% -348,778.58%
Return on Equity Simple (ROE_SIMPLE)		 0.00% -26.63% 62.15% 43.92% -54.05% 318.54% 177.50% -11.21% -122.50% 252.03%
Net Operating Profit after Tax (NOPAT)		 1,086 387 1,145 853 -1,070 -763 2,734 17,516 -1,453 -1,018
NOPAT Margin		 9.17% 3.06% 7.70% 5.71% -8.22% -6.77% 14.43% 101.24% -10.85% -8.14%
Net Nonoperating Expense Percent (NNEP)		 0.00% 13.12% -0.40% 1.27% -4.47% 5.84% 2.41% 358.87% -39.06% 42.73%
Return On Investment Capital (ROIC_SIMPLE)		 - - - - - - - 166.50% -11.93% -9.45%
Cost of Revenue to Revenue		 78.28% 79.21% 83.42% 86.45% 103.60% 102.80% 76.82% 95.68% 108.16% 105.04%
SG&A Expenses to Revenue		 2.34% 6.53% 5.85% 6.00% 7.66% 6.44% 4.33% 5.33% 6.75% 5.98%
R&D to Revenue		 0.36% 0.39% 0.34% 0.38% 0.47% 0.43% 0.28% 0.41% 0.59% 0.60%
Operating Expenses to Revenue		 4.73% 16.42% 6.19% 6.38% 8.13% 6.87% 4.62% 5.74% 7.34% 6.58%
Earnings before Interest and Taxes (EBIT)		 1,766 -434 1,407 777 -1,357 -1,980 2,938 -258 -1,623 -3,163
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)		 2,303 391 2,292 1,548 -453 -1,201 3,688 638 -550 -2,363
Valuation Ratios		 - - - - - - - - - -
Price to Book Value (P/BV)		 0.00 0.00 0.00 0.00 2.41 0.00 10.77 3.24 3.81 0.00
Price to Tangible Book Value (P/TBV)		 0.00 0.00 0.00 0.00 5.54 0.00 31.82 6.54 12.43 0.00
Price to Revenue (P/Rev)		 0.00 0.00 0.00 0.00 0.22 0.16 0.44 0.21 0.26 0.12
Price to Earnings (P/E)		 0.00 0.00 0.00 0.00 0.00 0.00 3.36 0.00 0.00 0.00
Dividend Yield		 4.52% 9.61% 3.82% 9.44% 19.09% 0.00% 12.85% 0.00% 0.00% 0.00%
Earnings Yield		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 29.74% 0.00% 0.00% 0.00%
Enterprise Value to Invested Capital (EV/IC)		 0.00 0.00 0.00 0.00 0.99 0.78 1.51 4.41 5.85 4.15
Enterprise Value to Revenue (EV/Rev)		 0.00 0.00 0.00 0.00 0.82 0.67 0.79 0.58 0.81 0.82
Enterprise Value to EBITDA (EV/EBITDA)		 0.00 0.00 0.00 0.00 0.00 0.00 4.03 15.60 0.00 0.00
Enterprise Value to EBIT (EV/EBIT)		 0.00 0.00 0.00 0.00 0.00 0.00 5.06 0.00 0.00 0.00
Enterprise Value to NOPAT (EV/NOPAT)		 0.00 0.00 0.00 0.00 0.00 0.00 5.44 0.57 0.00 0.00
Enterprise Value to Operating Cash Flow (EV/OCF)		 0.00 0.00 0.00 0.00 0.00 2.01 26.36 5.28 126.79 19.32
Enterprise Value to Free Cash Flow (EV/FCFF)		 0.00 0.00 0.00 0.00 0.00 18.90 6.00 0.40 0.00 0.00
Leverage & Solvency		 - - - - - - - - - -
Debt to Equity		 0.00 13.56 4.27 4.45 10.26 -12.69 8.06 8.10 17.03 -16.58
Long-Term Debt to Equity		 0.00 12.05 4.05 4.32 7.71 -11.19 5.87 6.16 13.21 -12.71
Financial Leverage		 0.00 17.62 8.48 5.75 7.57 84.93 51.85 4.34 1.25 -272.29
Leverage Ratio		 0.00 30.12 14.60 9.99 13.17 141.38 90.05 14.66 19.42 -2,208.95
Compound Leverage Factor		 0.00 14.75 16.49 11.95 11.11 133.12 98.74 -0.13 15.28 -2,002.62
Debt to Total Capital		 0.00% 93.13% 81.04% 81.66% 91.12% 108.56% 88.97% 89.02% 94.45% 106.42%
Short-Term Debt to Total Capital		 0.00% 10.36% 4.20% 2.48% 22.65% 12.77% 24.24% 21.37% 21.21% 24.84%
Long-Term Debt to Total Capital		 0.00% 82.78% 76.84% 79.18% 68.47% 95.78% 64.73% 67.65% 73.24% 81.58%
Preferred Equity to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital		 0.00% -4.06% -2.87% -2.84% -2.12% -3.68% -2.96% -2.18% -1.21% 0.76%
Common Equity to Total Capital		 0.00% 10.93% 21.83% 21.18% 11.00% -4.94% 7.74% 10.76% 7.58% -6.44%
Debt to EBITDA		 0.00 18.35 3.08 4.19 -22.22 -7.87 2.43 14.68 -20.91 -4.85
Net Debt to EBITDA		 0.00 12.04 2.28 2.86 -17.52 -5.05 1.84 10.21 -13.63 -3.67
Long-Term Debt to EBITDA		 0.00 16.31 2.92 4.06 -16.70 -6.94 1.77 11.16 -16.21 -3.72
Debt to NOPAT		 0.00 18.53 6.16 7.61 -9.42 -12.38 3.28 0.53 -7.92 -11.26
Net Debt to NOPAT		 0.00 12.16 4.56 5.19 -7.42 -7.94 2.48 0.37 -5.16 -8.52
Long-Term Debt to NOPAT		 0.00 16.47 5.85 7.38 -7.08 -10.92 2.39 0.41 -6.14 -8.63
Altman Z-Score		 0.00 0.00 0.00 0.00 0.76 0.38 2.29 1.29 0.68 0.09
Noncontrolling Interest Sharing Ratio		 0.00% -59.15% -25.80% -15.30% -18.86% -231.24% 4.95% 15.69% -12.24% 1,531.28%
Liquidity Ratios		 - - - - - - - - - -
Current Ratio		 0.00 0.69 0.94 0.92 1.44 1.20 1.56 1.42 1.53 1.31
Quick Ratio		 0.00 0.42 0.52 0.50 0.70 0.80 0.81 0.78 0.94 0.75
Cash Flow Metrics		 - - - - - - - - - -
Free Cash Flow to Firm (FCFF)		 0.00 -9,462 158 1,549 -1,698 398 2,479 25,126 -1,059 -1,639
Operating Cash Flow to CapEx		 -6.18% 32.68% -273.92% 174.76% -700.25% 711.37% 93.08% 205.39% 9.33% 88.93%
Free Cash Flow to Firm to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow to Interest Expense		 -0.07 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow Less CapEx to Interest Expense		 -1.12 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Efficiency Ratios		 - - - - - - - - - -
Asset Turnover		 0.00 0.79 0.93 0.96 0.81 0.67 1.14 1.04 0.75 0.71
Accounts Receivable Turnover		 0.00 22.68 18.19 15.05 15.97 13.09 15.41 15.67 17.62 16.98
Inventory Turnover		 0.00 5.82 6.66 6.16 6.60 6.60 6.41 5.93 5.53 5.48
Fixed Asset Turnover		 0.00 1.40 1.65 1.74 1.60 1.51 2.79 0.00 0.00 0.00
Accounts Payable Turnover		 0.00 4.64 6.58 6.59 5.61 5.14 6.52 6.52 5.00 4.21
Days Sales Outstanding (DSO)		 0.00 16.10 20.07 24.26 22.86 27.89 23.69 23.29 20.71 21.49
Days Inventory Outstanding (DIO)		 0.00 62.66 54.80 59.21 55.26 55.31 56.98 61.56 65.98 66.57
Days Payable Outstanding (DPO)		 0.00 78.60 55.44 55.38 65.08 70.95 56.00 55.98 73.01 86.69
Cash Conversion Cycle (CCC)		 0.00 0.16 19.43 28.08 13.04 12.24 24.67 28.88 13.68 1.37
Capital & Investment Metrics		 - - - - - - - - - -
Invested Capital		 0.00 9,849 10,836 10,141 10,769 9,608 9,863 2,253 1,859 2,480
Invested Capital Turnover		 0.00 2.57 1.44 1.43 1.25 1.11 1.95 2.86 6.51 5.77
Increase / (Decrease) in Invested Capital		 0.00 9,849 988 -696 629 -1,161 255 -7,610 -394 621
Enterprise Value (EV)		 0.00 0.00 0.00 0.00 10,632 7,522 14,879 9,947 10,870 10,293
Market Capitalization		 0.00 0.00 0.00 0.00 2,928 1,783 8,407 3,663 3,516 1,539
Book Value per Share		 $0.00 $0.00 $2.39 $3.73 $2.69 ($0.95) $0.98 $1.42 $1.16 ($0.87)
Tangible Book Value per Share		 $0.00 $0.00 $1.35 $2.16 $1.17 ($2.16) $0.33 $0.70 $0.35 ($1.56)
Total Capital		 0.00 7,701 8,714 7,946 11,051 8,700 10,086 10,520 12,185 10,776
Total Debt		 0.00 7,172 7,062 6,489 10,070 9,445 8,973 9,365 11,509 11,468
Total Long-Term Debt		 0.00 6,374 6,696 6,291 7,567 8,333 6,529 7,116 8,925 8,791
Net Debt		 0.00 4,706 5,222 4,425 7,938 6,060 6,770 6,514 7,501 8,673
Capital Expenditures (CapEx)		 843 795 674 673 664 525 606 917 919 599
Debt-free, Cash-free Net Working Capital (DFCFNWC)		 0.00 -3,797 -1,816 -2,294 2,174 -1,145 2,784 1,369 1,279 1,370
Debt-free Net Working Capital (DFNWC)		 0.00 -1,368 20 -249 4,288 2,229 4,974 4,191 5,253 4,094
Net Working Capital (NWC)		 0.00 -2,166 -346 -446 1,785 1,117 2,529 1,943 2,668 1,417
Net Nonoperating Expense (NNE)		 388 611 -37 114 -413 588 230 17,672 -446 930
Net Nonoperating Obligations (NNO)		 0.00 9,320 9,184 8,683 9,788 10,353 8,751 1,098 1,183 3,172
Total Depreciation and Amortization (D&A)		 537 825 884 771 904 779 749 895 1,073 800
Debt-free, Cash-free Net Working Capital to Revenue		 0.00% -30.01% -12.21% -15.35% 16.70% -10.16% 14.69% 7.91% 9.55% 10.95%
Debt-free Net Working Capital to Revenue		 0.00% -10.82% 0.14% -1.67% 32.93% 19.77% 26.25% 24.23% 39.22% 32.71%
Net Working Capital to Revenue		 0.00% -17.12% -2.33% -2.99% 13.71% 9.91% 13.35% 11.23% 19.92% 11.32%
Earnings Adjustments		 - - - - - - - - - -
Adjusted Basic Earnings per Share		 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $18.15 ($1.26) ($17.24) ($6.89)
Adjusted Weighted Average Basic Shares Outstanding		 0.00 0.00 797.26M 451.67M 451.67M 797.22M 796.31M 797.21M 797.21M 797.21M
Adjusted Diluted Earnings per Share		 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $18.10 ($1.26) ($17.24) ($6.89)
Adjusted Weighted Average Diluted Shares Outstanding		 0.00 0.00 797.26M 451.67M 451.67M 797.22M 796.31M 797.21M 797.21M 797.21M
Adjusted Basic & Diluted Earnings per Share		 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 0.00 0.00 797.26M 451.67M 451.67M 797.22M 796.31M 797.21M 797.21M 797.21M
Normalized Net Operating Profit after Tax (NOPAT)		 1,086 387 1,145 853 -1,070 -763 2,734 -172 -1,453 -1,018
Normalized NOPAT Margin		 9.17% 3.06% 7.70% 5.71% -8.22% -6.77% 14.43% -0.99% -10.85% -8.14%
Pre Tax Income Margin		 9.42% -1.68% 10.69% 6.22% -8.80% -16.54% 17.00% 0.01% -9.54% -22.91%
Debt Service Ratios		 - - - - - - - - - -
EBIT to Interest Expense		 2.21 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT to Interest Expense		 1.36 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
EBIT Less CapEx to Interest Expense		 1.16 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT Less CapEx to Interest Expense		 0.30 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Payout Ratios		 - - - - - - - - - -
Dividend Payout Ratio		 17.47% -274.00% 25.51% 52.29% -25.33% -0.03% 42.92% -164.43% -0.14% -0.05%
Augmented Payout Ratio		 17.47% -274.00% 25.51% 52.29% -25.33% -0.03% 42.92% -164.43% -0.14% -0.05%

Quarterly Metrics and Ratios for Braskem

No quarterly metrics and ratios for Braskem are available.

Frequently Asked Questions About Braskem's Financials

When does Braskem's fiscal year end?

According to the most recent income statement we have on file, Braskem's financial year ends in December. Their financial year 2024 ended on December 31, 2024.

How has Braskem's net income changed over the last 9 years?

Braskem's net income appears to be on an upward trend, with a most recent value of -$1.95 billion in 2024, falling from $697.14 million in 2015. The previous period was -$1.01 billion in 2023.

What is Braskem's operating income?
Braskem's total operating income in 2024 was -$1.45 billion, based on the following breakdown:
  • Total Gross Profit: $969.76 million
  • Total Operating Expenses: $823.58 million
How has Braskem revenue changed over the last 9 years?

Over the last 9 years, Braskem's total revenue changed from $11.84 billion in 2015 to $12.52 billion in 2024, a change of 5.7%.

How much debt does Braskem have?

Braskem's total liabilities were at $15.91 billion at the end of 2024, a 3.5% decrease from 2023, and a 55.9% increase since 2016.

How much cash does Braskem have?

In the past 8 years, Braskem's cash and equivalents has ranged from $1.14 billion in 2017 to $2.92 billion in 2023, and is currently $2.42 billion as of their latest financial filing in 2024.

How has Braskem's book value per share changed over the last 9 years?

Over the last 9 years, Braskem's book value per share changed from 0.00 in 2015 to -0.87 in 2024, a change of -87.1%.

Remove Ads

Related Companies

This page (NYSE:BAK) was last updated on 4/16/2025 by MarketBeat.com Staff
From Our Partners
Two Unmistakable Patterns Return…
The signs suggest we're entering one of those rare periods now. That's why Central Banks are buying gold at...
Golden Portfolio | Sponsored
Why Elon put $51 million into this
Why Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT Scientists
True Market Insiders | Sponsored
Crypto’s crashing…but we’re still profiting
Most traders are panicking right now. Bitcoin’s dropping. Altcoins are bleeding. The stock market’s a mess....
Crypto Swap Profits | Sponsored
Is it CRAZY to still want reliable profits, despite this market?
Larry Benedict, the acclaimed "Market Wizard," is calling an emergency briefing now... The same Larry who –...
Brownstone Research | Sponsored
REVEALED FREE: Our top 3 stocks to own in 2025 and beyond
Every time Weiss Ratings flashed green like this, the average gain on each and every stock has been 303% (incl...
Weiss Ratings | Sponsored
Tariffs. Volatility. Fear. Here’s the Plan.
Wall Street's panicking over tariffs. Volatility's back with a vengeance. If you've been glued to the he...
Investors Alley | Sponsored
Trump 2028 could be a “bonanza” for investors
As you may have heard, Donald Trump is planning to run for a THIRD term in 2028. Recently he told NBC news ...
Paradigm Press | Sponsored
Musk’s AI Masterplan – Our #1 AI Stock to Buy Now
Did Elon Musk just set the stage for the next AI stock explosion? One 30-year Wall Street veteran thinks so...
Behind the Markets | Sponsored